Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_assertion evidence source_evidence_literature NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_assertion SIO_000772 14601054 NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_assertion wasDerivedFrom befree-20140225 NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_assertion wasGeneratedBy ECO_0000203 NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
- befree-20140225 importedOn "2014-02-25" NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.